DAVITA INC (DVA) Fundamental Analysis & Valuation

NYSE:DVA • US23918K1088

154.81 USD
+3.26 (+2.15%)
At close: Mar 11, 2026
154.81 USD
0 (0%)
After Hours: 3/11/2026, 7:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This DVA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

DVA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. DVA scores excellent on profitability, but there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on DVA.


Dividend Valuation Growth Profitability Health

7

1. DVA Profitability Analysis

1.1 Basic Checks

  • DVA had positive earnings in the past year.
  • DVA had a positive operating cash flow in the past year.
  • Each year in the past 5 years DVA has been profitable.
  • Each year in the past 5 years DVA had a positive operating cash flow.
DVA Yearly Net Income VS EBIT VS OCF VS FCFDVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • With a decent Return On Assets value of 4.27%, DVA is doing good in the industry, outperforming 73.27% of the companies in the same industry.
  • DVA has a better Return On Invested Capital (11.22%) than 83.17% of its industry peers.
  • DVA had an Average Return On Invested Capital over the past 3 years of 10.38%. This is in line with the industry average of 8.98%.
  • The last Return On Invested Capital (11.22%) for DVA is above the 3 year average (10.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.27%
ROE N/A
ROIC 11.22%
ROA(3y)4.59%
ROA(5y)4.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)9.62%
DVA Yearly ROA, ROE, ROICDVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600

1.3 Margins

  • DVA has a better Profit Margin (5.47%) than 81.19% of its industry peers.
  • DVA's Profit Margin has declined in the last couple of years.
  • DVA has a Operating Margin of 14.74%. This is amongst the best in the industry. DVA outperforms 91.09% of its industry peers.
  • DVA's Operating Margin has been stable in the last couple of years.
  • The Gross Margin of DVA (32.25%) is better than 61.39% of its industry peers.
  • DVA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.74%
PM (TTM) 5.47%
GM 32.25%
OM growth 3Y9.25%
OM growth 5Y0.22%
PM growth 3Y4.31%
PM growth 5Y-3.96%
GM growth 3Y3.26%
GM growth 5Y0.9%
DVA Yearly Profit, Operating, Gross MarginsDVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DVA Health Analysis

2.1 Basic Checks

  • DVA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • DVA has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DVA has less shares outstanding
  • DVA has a worse debt/assets ratio than last year.
DVA Yearly Shares OutstandingDVA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
DVA Yearly Total Debt VS Total AssetsDVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.53, we must say that DVA is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.53, DVA is in line with its industry, outperforming 41.58% of the companies in the same industry.
  • DVA has a debt to FCF ratio of 7.84. This is a slightly negative value and a sign of low solvency as DVA would need 7.84 years to pay back of all of its debts.
  • DVA has a Debt to FCF ratio (7.84) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.84
Altman-Z 1.53
ROIC/WACC1.43
WACC7.83%
DVA Yearly LT Debt VS Equity VS FCFDVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • DVA has a Current Ratio of 1.29. This is a normal value and indicates that DVA is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.29, DVA is in line with its industry, outperforming 51.49% of the companies in the same industry.
  • DVA has a Quick Ratio of 1.24. This is a normal value and indicates that DVA is financially healthy and should not expect problems in meeting its short term obligations.
  • DVA has a Quick ratio (1.24) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.24
DVA Yearly Current Assets VS Current LiabilitesDVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. DVA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 9.37% over the past year.
  • The Earnings Per Share has been growing slightly by 7.46% on average over the past years.
  • The Revenue has been growing slightly by 6.46% in the past year.
  • The Revenue has been growing slightly by 3.39% on average over the past years.
EPS 1Y (TTM)9.37%
EPS 3Y22.66%
EPS 5Y7.46%
EPS Q2Q%51.79%
Revenue 1Y (TTM)6.46%
Revenue growth 3Y5.53%
Revenue growth 5Y3.39%
Sales Q2Q%9.87%

3.2 Future

  • DVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.56% yearly.
  • DVA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.41% yearly.
EPS Next Y36.12%
EPS Next 2Y26.52%
EPS Next 3Y22.72%
EPS Next 5Y20.56%
Revenue Next Year3.76%
Revenue Next 2Y3.4%
Revenue Next 3Y3.7%
Revenue Next 5Y5.41%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DVA Yearly Revenue VS EstimatesDVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
DVA Yearly EPS VS EstimatesDVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

8

4. DVA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.90, which indicates a correct valuation of DVA.
  • DVA's Price/Earnings ratio is rather cheap when compared to the industry. DVA is cheaper than 82.18% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.15, DVA is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 10.95, which indicates a very decent valuation of DVA.
  • Based on the Price/Forward Earnings ratio, DVA is valued cheaper than 88.12% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of DVA to the average of the S&P500 Index (24.27), we can say DVA is valued rather cheaply.
Industry RankSector Rank
PE 14.9
Fwd PE 10.95
DVA Price Earnings VS Forward Price EarningsDVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DVA is valued cheaper than 84.16% of the companies in the same industry.
  • 87.13% of the companies in the same industry are more expensive than DVA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.89
EV/EBITDA 7.22
DVA Per share dataDVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 -100 200

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of DVA may justify a higher PE ratio.
  • DVA's earnings are expected to grow with 22.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.41
PEG (5Y)2
EPS Next 2Y26.52%
EPS Next 3Y22.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DVA Dividend Analysis

5.1 Amount

  • DVA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DVA Fundamentals: All Metrics, Ratios and Statistics

DAVITA INC

NYSE:DVA (3/11/2026, 7:00:00 PM)

After market: 154.81 0 (0%)

154.81

+3.26 (+2.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-02
Earnings (Next)05-11
Inst Owners52.81%
Inst Owner Change0.26%
Ins Owners4.96%
Ins Owner Change-0.02%
Market Cap10.34B
Revenue(TTM)13.64B
Net Income(TTM)746.80M
Analysts67.14
Price Target154.54 (-0.17%)
Short Float %18.8%
Short Ratio5.99
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.32%
Min EPS beat(2)-37.31%
Max EPS beat(2)6.68%
EPS beat(4)3
Avg EPS beat(4)-6.2%
Min EPS beat(4)-37.31%
Max EPS beat(4)6.68%
EPS beat(8)5
Avg EPS beat(8)-2.1%
EPS beat(12)9
Avg EPS beat(12)2.69%
EPS beat(16)10
Avg EPS beat(16)-2.86%
Revenue beat(2)1
Avg Revenue beat(2)0.63%
Min Revenue beat(2)-1.24%
Max Revenue beat(2)2.49%
Revenue beat(4)1
Avg Revenue beat(4)0.09%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)2.49%
Revenue beat(8)3
Avg Revenue beat(8)0.05%
Revenue beat(12)7
Avg Revenue beat(12)0.59%
Revenue beat(16)7
Avg Revenue beat(16)-0.06%
PT rev (1m)8.99%
PT rev (3m)9.33%
EPS NQ rev (1m)-3.49%
EPS NQ rev (3m)-2.07%
EPS NY rev (1m)6.93%
EPS NY rev (3m)10.72%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-0.18%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)0.76%
Valuation
Industry RankSector Rank
PE 14.9
Fwd PE 10.95
P/S 0.76
P/FCF 7.89
P/OCF 5.48
P/B N/A
P/tB N/A
EV/EBITDA 7.22
EPS(TTM)10.39
EY6.71%
EPS(NY)14.14
Fwd EY9.14%
FCF(TTM)19.62
FCFY12.67%
OCF(TTM)28.24
OCFY18.24%
SpS204.24
BVpS-9.75
TBVpS-126.02
PEG (NY)0.41
PEG (5Y)2
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 4.27%
ROE N/A
ROCE 14.02%
ROIC 11.22%
ROICexc 11.79%
ROICexgc 27.39%
OM 14.74%
PM (TTM) 5.47%
GM 32.25%
FCFM 9.61%
ROA(3y)4.59%
ROA(5y)4.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)9.62%
ROICexc(3y)10.88%
ROICexc(5y)10.02%
ROICexgc(3y)24.5%
ROICexgc(5y)21.86%
ROCE(3y)12.97%
ROCE(5y)12.02%
ROICexgc growth 3Y20.64%
ROICexgc growth 5Y7.57%
ROICexc growth 3Y16.27%
ROICexc growth 5Y4.4%
OM growth 3Y9.25%
OM growth 5Y0.22%
PM growth 3Y4.31%
PM growth 5Y-3.96%
GM growth 3Y3.26%
GM growth 5Y0.9%
F-Score6
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.84
Debt/EBITDA 3.73
Cap/Depr 80.5%
Cap/Sales 4.22%
Interest Coverage 3.9
Cash Conversion 69.2%
Profit Quality 175.5%
Current Ratio 1.29
Quick Ratio 1.24
Altman-Z 1.53
F-Score6
WACC7.83%
ROIC/WACC1.43
Cap/Depr(3y)77.81%
Cap/Depr(5y)82.01%
Cap/Sales(3y)4.41%
Cap/Sales(5y)4.79%
Profit Quality(3y)182.58%
Profit Quality(5y)170.25%
High Growth Momentum
Growth
EPS 1Y (TTM)9.37%
EPS 3Y22.66%
EPS 5Y7.46%
EPS Q2Q%51.79%
EPS Next Y36.12%
EPS Next 2Y26.52%
EPS Next 3Y22.72%
EPS Next 5Y20.56%
Revenue 1Y (TTM)6.46%
Revenue growth 3Y5.53%
Revenue growth 5Y3.39%
Sales Q2Q%9.87%
Revenue Next Year3.76%
Revenue Next 2Y3.4%
Revenue Next 3Y3.7%
Revenue Next 5Y5.41%
EBIT growth 1Y2.85%
EBIT growth 3Y15.29%
EBIT growth 5Y3.61%
EBIT Next Year39.73%
EBIT Next 3Y14.35%
EBIT Next 5Y12.19%
FCF growth 1Y-10.63%
FCF growth 3Y10.89%
FCF growth 5Y0.09%
OCF growth 1Y-6.7%
OCF growth 3Y6.44%
OCF growth 5Y-0.95%

DAVITA INC / DVA FAQ

What is the ChartMill fundamental rating of DAVITA INC (DVA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to DVA.


What is the valuation status of DAVITA INC (DVA) stock?

ChartMill assigns a valuation rating of 8 / 10 to DAVITA INC (DVA). This can be considered as Undervalued.


Can you provide the profitability details for DAVITA INC?

DAVITA INC (DVA) has a profitability rating of 7 / 10.


How financially healthy is DAVITA INC?

The financial health rating of DAVITA INC (DVA) is 3 / 10.


What is the expected EPS growth for DAVITA INC (DVA) stock?

The Earnings per Share (EPS) of DAVITA INC (DVA) is expected to grow by 36.12% in the next year.